Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

Showing 1-10 of 595

31 Jan 2020  |  North America

Predictions for the Global Life Sciences Industry, 2020

2020 is Expected to be a Landmark Year for New Digital-tech Adoption, and Sustainable Pricing Models will Encourage Stronger, New Product Pipelines

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

USD 1,500.00
27 Jan 2020  |  Global

Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022

Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth

The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...

USD 4,950.00
10 Jan 2020  |  Asia Pacific

Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025

Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10% of the market. The market being highly dependent on its distributor networks, l...

USD 10,000.00
30 Dec 2019  |  Global

Novel Enzyme Technologies for Pharmaceutical Applications

A Review of Novel Enzyme Technologies and Enzyme Applications in API Production, Therapeutics, Diagnosis, Medical Detergents, and Enzyme Expression Systems, Including Enzyme Manufacturing for Pharmaceuticals

The current study discusses the novel enzyme technologies for enzyme discovery and improvement such as directed mutagenesis, metagenomics, artificial intelligence and computational biology approaches and highthroughput technologies used for generation of enzyme variant libraries. Additionally, novel enzyme applications and potential applications in...

USD 4,950.00
17 Dec 2019  |  Global

Emerging Microbiome Technologies for Applications in Skin Care

Microbiome-based Innovations Transforming the Personal Care Landscape

Skin microbiome industry has been rapidly evolving since the past few years and is likely to witness new innovations in the near future. Apart from emerging new start-ups in this area, several leading cosmetic and industry participants are likely to shift focus towards emerging microbiome-based beauty platforms.As the consumer focuses towards the...

USD 4,950.00
02 Dec 2019  |  North America

Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024

Advancements in Continuous Manufacturing Technology, Necessary to Meet New Demand in the Orphan Drugs Segment and Personalized Medicine, Will Give a New Growth Vector to CMOs

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

USD 4,950.00
27 Nov 2019  |  North America

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...

USD 4,950.00
06 Nov 2019  |  North America

Growth Opportunities in Human Microbiome Market, Forecast to 2023

Strategic Collaborations and Stakeholder Awareness Along with Clear Paths to Commercialization will Play a Key Role for Success in the Human Microbiome Market

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...

USD 4,950.00
04 Nov 2019  |  North America

Global Laboratory Products Purchasing Trends, 2019–2020

An End-user Perspective on Laboratory Spending Reveals Modest 2020 Budget Increases Following Healthier 2019 Spending

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2019 that centered around the state of their laboratories in 2019 and their expectations for 2020. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year...

USD 1,500.00
26 Sep 2019  |  Global

Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022

Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

USD 4,950.00

Showing 1-10 of 595